Ideaya Biosciences Long Term Debt

Ideaya Biosciences (IDYA) currently reports a long-term debt of $28M as of June 2026. That compares with $26M in the prior-year period — up 7.0% year over year. Use the charts on this page to explore Ideaya Biosciences's long-term debt history and peer comparisons.

Ideaya Biosciences's long-term debt increased from $26M to $28M — a 7.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ideaya Biosciences reported $28M in long-term debt as of June 2026. That compares with $26M in the prior-year period — up 7.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $28M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ideaya Biosciences, and consider following IDYA for alerts when major investors trade the stock.

Ideaya Biosciences is classified in the Healthcare sector. On long-term debt, it currently shows $28M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IDYA with unrelated industries.